RECURRENT GLIOSARCOMA

Clinical trials for RECURRENT GLIOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT GLIOSARCOMA trials appear

Sign up with your email to follow new studies for RECURRENT GLIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 2

Experimental combo targets Hard-to-Treat brain tumors

Disease control Not yet recruiting

This early-phase trial tests a new two-drug combination for people whose glioblastoma (a severe brain cancer) has returned after initial treatment. The study combines a radioactive antibody that seeks out cancer cells with an immunotherapy drug that helps the immune system fight …

Matched conditions: RECURRENT GLIOSARCOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 01, 2026 16:00 UTC

RECURRENT GLIOSARCOMA

Get alerted when new RECURRENT GLIOSARCOMA trials appear

Experimental combo targets Hard-to-Treat brain tumors